Roche Under Fire Over ‘Unaffordable’ COVID-19 Therapy Actemra

The WHO Calls For Lower Prices

 
• By Andrew McConaghie
  
Peru COVID-19 ward
Honorio Delgado Hospital in Arequipa, Peru: access to Roche's Actemra is limited in many developing nations. • Source: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip